Zydus Lifesciences’ joint venture (JV) -- Zydus Sunshine Lifesciences has inked an agreement with the Board of Investment of Sri Lanka to establish a pharmaceutical manufacturing facility in the BOI zone in Horana, Sri Lanka. The Zydus Sunshine Lifesciences is a joint venture between the company and Sunshine Healthcare, part of Sunshine Holdings PLC.
The project envisages a phased investment of over $20 million. The facility will be developed on a site of nearly four acres, with commercial operations expected to commence in 2028, subject to project timelines and relevant regulatory approvals.
In its first phase, the facility will manufacture oral solid dosage forms for the Sri Lankan market. The investment supports the company’s international presence and commitment to expanding access to quality medicines. Local manufacturing is expected to strengthen medicine supply chain resilience and support the availability of essential medicines in Sri Lanka.
Zydus Lifesciences is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating, manufacturing, marketing and selling of finished dosage human formulations, active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
